Pluribus Labs’s Broadridge BR Stock Holding History

Pluribus Labs’s Portfolio BR Stock Details BR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,086	Closed	-$381K	–	77
2021 Q4	$381K	Buy	+2,086	New	+$367K	0.4%	90

Other funds holding BR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JIM

Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return

Pluribus Labs's BR Position: Q1 2022 in Review

Pluribus Labs sold out of Broadridge (BR) in Q1 2022, closing a stake of 2,086 shares — an estimated $381K sold.

Pluribus Labs first reported a position in BR in Q4 2021 and held it in 1 quarter. The position peaked at $381K in Q4 2021. 776 funds tracked by Wall St. Rank hold BR as of Q1 2022.

Pluribus Labs reported no remaining Broadridge position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 2,086 Broadridge shares in Q1 2022, an estimated $381K.
Pluribus Labs first reported a position in Broadridge in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Broadridge position peaked at $381K in Q4 2021.
776 funds tracked by Wall St. Rank held Broadridge as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.